Walter Verbeek

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants

Rüdiger Hehlmann, Michael Lauseker, Susanne Saußele et al. · Leukemia · 2017 · 339 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

JAK Inhibition Impairs NK Cell Function in Myeloproliferative Neoplasms

Kathrin Schönberg, Janna Rudolph, Maria Vonnahme et al. · Cancer Research · 2015 · 179 citations

Life Sciences, Immunology, Pharmacology +17

Evidence for malignant transformation in acute myeloid leukemia at the level of early hematopoietic stem cells by cytogenetic analysis of CD34+ subpopulations

D. Haase, Michaela Feuring‐Buske, Stephanie Könemann et al. · Blood · 1995 · 156 citations · Full text

Life Sciences, Cell Biology, Hematology +17

A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromes

Michael Stadler, Ulrich Germing, Kliche Ko et al. · Leukemia · 2004 · 138 citations

Life Sciences, Immunology, Clinical Immunology +10

A genetic map of an interspecific cross in Allium based on amplified fragment length polymorphism (AFLPTM) markers

A.W. van Heusden, J.W. van Ooijen, R. Vrielink-van Ginkel et al. · Theoretical and Applied Genetics · 2000 · 137 citations

Life Sciences, Genetics, Molecular Genetics +8